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Abstract 
The gram-negative bacterium Yersinia pestis, the aetiological agent of bubonic 
plague, is one the deadliest pathogens known to man.  Despite its historical reputation, 
plague is a modern disease which annually afflicts thousands of people.  Public safety 
considerations greatly limit clinical experimentation on this organism and thus 
development of theoretical tools to analyze the capabilities of this pathogen is of 
utmost importance.   
Here, we report the first genome-scale metabolic model of Yersinia pestis biovar 
Mediaevalis based both on its recently annotated genome, and physiological and 
biochemical data from literature.  Our model demonstrates excellent agreement with 
Y. pestis’ known metabolic needs and capabilities.  Since Y. pestis is a meiotrophic 
organism, we have developed CryptFind, a systematic approach to identify all 
candidate cryptic genes responsible for known and theoretical meiotrophic 
phenomena.  In addition to uncovering every known cryptic gene for Y. pestis, our 
analysis of the rhamnose fermentation pathway suggests that betB is the responsible 
cryptic gene.   
Despite all of our medical advances, we still do not have a vaccine for bubonic 
plague.  Recent discoveries of antibiotic resistant strains of Yersinia pestis coupled 
with the threat of plague being used as a bioterrorism weapon compel us to develop 
new tools for studying the physiology of this deadly pathogen.  Using our theoretical 
model, we can study the cell’s phenotypic behavior under different circumstances and 
identify metabolic weaknesses which may be harnessed for the development of 
therapeutics.  Additionally, the automatic identification of cryptic genes expands the 
usage of genomic data for pharmaceutical purposes.    
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Introduction  
 
The “black death” pandemic that ravaged Europe between the 14
th
 to 16
th
 centuries is 
the most infamous outbreak of pestilence in history.  Within a short five-year period 
(1347-1352), thirty three million people, one out of every three Europeans perished.  
The Mediaevalis biovar of the gram-negative bacterium Yersinia pestis (YP), the 
aetiological agent of bubonic plague, is believed to have caused this epidemic 
1, 2
.  
The most recent outbreak of bubonic plague in Asia killed nearly 12.5 million people 
in India alone from 1889 to 1950. Throughout human history, a conservative estimate 
stipulates that 200 million people have been victims to this deadly disease in various 
pandemics 
3
.  Despite modern advances in medicine, no working vaccine against the 
plague exists, and it is listed by the US Centers for Disease Control and Prevention 
(CDC) as a Category A bio-terrorism pathogen.  While plague is frequently 
considered a disease of the past, several thousand new cases are reported each year, 
predominantly in Africa 
4
.  Between 1990 to 1995, the Democratic Republic of 
Congo, Tanzania and Zimbabwe alone reported 4939 cases of plague 
5
.  Hence, the 
recent reports of antibiotic resistant strains of YP 
6-8
 are cause for great alarm.   
Over the past decade, the revolutionary advances in high-throughput technologies and 
computational approaches have led to the inception of systems biology, which aims to 
transform microbiology from a science which focuses on one specific cellular process 
or pathway, to one that the biology of the system as a whole is examined.  To achieve 
this goal, genome-scale models of metabolism have been developed using constraint-
based approaches with flux-balance analysis (FBA) being the most widely used 
method.  FBA’s success originates from the fact that, unlike kinetic models, FBA only 
seeks to identify optimal metabolic steady-state activity patterns that satisfy 
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constraints imposed by mass balance, the metabolic network structure, and the 
availability of nutrients.  The most common objective function (cellular task to be 
optimized) is that of growth, although other choices are possible depending on the 
selective environment of the cell 
9
.  FBA has been applied to several genome-scale 
models 
10-14
 with great success.  Additionally,  FBA has been used to examine a range 
of topics from the global organization of metabolic fluxes 
15
 to the effect of genetic 
knockouts 
16
 and the discovery of novel regulatory interactions 
17
.   However, the 
overall process of system building is still highly labor intensive and requires extensive 
human curation to generate high-fidelity models.   
Here, we present and analyze the first genome-scale reconstruction of an organism 
classified by the CDC as a Category A pathogen.  We demonstrate excellent 
agreement with known metabolic performance for YP.  The model predictions match 
the identified nutritional requirements and metabolic efficiency of YP, as well as 
established characteristics for biovar Mediaevalis and strain 91001.   Furthermore, we 
have developed a general method based on FBA for the identification of candidate 
cryptic and pseudogenes.  Applying it to seven meiotrophic pathways of YP, we 
identify known cryptic genes for the phenylalanine, methionine, and urease pathways 
in addition to novel cryptic gene candidates for the other pathways.   
Results  
 
Metabolic network reconstruction  
The Yersinia pestis model iAN818m is based on the sequenced genome of 
Mediaevalis strain 91001 
18
.  Of the 4037 genes present in the genome, 1146 are 
believed to be related to cellular metabolism.  Our model accounts for the activity of 
818 of these genes (71%), resulting in 969 enzymatic reactions.  Additional literature 
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surveys identified the activity of 37 local orphan enzymes (13-critical for biomass 
production, 20-based on literature, 4-pathway hole-filling) and 14 non-enzymatic 
reactions, resulting in a final model of 1020 reactions and 825 metabolites.     
Several studies 
19-22
 have shown that the composition of YP’s cellular membrane 
changes when the cell transitions from the flea gut environment (high Ca
2+
, 26°C) to 
that of the mammalian host (low Ca
2+
, 37°C).  We have implemented this change in 
our model by developing two separate biomass compositions.  The model includes the 
pathways for production of yersiniabactin virulence factor; however it currently does 
not contain the biosynthetic pathways for the production of other pathogenic proteins 
such as yersinia outer proteins.  A summary of the model characteristics is given in 
Table 1. Figure 1 displays the breakdown of reactions based on metabolic pathway 
affiliation.  This breakdown is similar to that of metabolism in a number of other 
modeled organisms. A complete list of the metabolic reactions is available in the 
Supplementary Material.   
 
Meiotrophy 
In the 1950s, it was realized that Yersinia pestis is a meiotrophic organism 
23
, and 
thus, its genome is replete with cryptic genes.  Cryptic genes are not transcribed by a 
cell under normal conditions, and are not critical for its proper functioning.  However, 
these genes may be activated through mutations when a cell’s environment has been 
perturbed such that their activity becomes crucial for cellular survival 
24, 25
.   While 
cryptic genes do not confer direct (positive) contributions to the fitness of a cell, they 
serve a crucial role in the survival of a species by endowing the organism with an 
endogenous genetic reservoir that enhances its adaptive capability 
25
.  Theoretical 
studies have shown that the loss or degradation of cryptic genes from a microbial 
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population is very rare, and that these genes may remain in a genome as long as 
selection for their reactivation occurs occasionally 
26
. 
The activation of cryptic genes during periods of natural selection has been reported 
in a number of bacteria.  For example, the mutational activation of the bgl operon 
enables some organisms to survive on an assortment of β-glucosides 27-29.  In 
Escherichia coli, the mutational reversal of a frameshift in the ilvG gene leads to 
expression of an α-acetohydroxyacid synthase isozyme which is not susceptible to 
feedback inhibition by valine 
30
.  Similarly, mutations in the citA and citB genes of E. 
coli provide the cell with the capability to utilize citrate as the sole carbon source 
31
.  
Since the metabolic potential of cells is enhanced by the activation of cryptic genes, 
the identification and targeted utilization of these genes has a significant potential for 
industrial and pharmacological benefits.   
In YP, meiotrophy has been observed in the biosynthetic pathways of 
glycine/threonine 
32, 33
, L-valine and L-isoleucine 
34
, L-phenylalanine 
32
, and L-
methionine 
23, 32
 as well as fermentation of melibiose 
35
, rhamnose 
36
, and in the urease 
pathway 
37
.  Consequently, our base-reconstruction predicts that none of these 
substrates are critical for growth since their metabolic capability is ostensibly present 
in the annotated genome.  For melibiose and rhamnose, the base-reconstruction is in 
agreement with experiments due to the fact that strain 91001 is different from most 
YP strains by being capable of utilizing these two carbohydrates as carbon sources
18
.  
To systematically identify candidate cryptic genes responsible for the observed 
meiotrophy in YP, we have developed the CryptFind approach that screens all 
available genes (see Methods).  The complete list of candidate cryptic genes 
responsible for observed meiotrophic behavior in YP metabolism is given in Table 2.   
In agreement with previous studies that have classified pheA, metB, and ureD as 
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cryptic genes 
38
, our approach identified these among the few candidate cryptic genes 
in their respective pathways.  Although strain 91001 is melibiose and rhamnose 
positive 
18
, we determined a number of candidate genes that in other strains of YP 
could be cryptic for these pathways.  In particular, gene YP1470, which translates into 
melibiose carrier protein MelB, has previously been designated as a cryptic gene 
18
.  
In case of rhamnose, we identify the candidate genes to be rhaT (L-rhamnose proton 
symport protein), rhaA (L-rhamnose isomerase; EC 5.3.1.14), tpiA (triose phosphate 
isomerase; EC 5.3.1.1), and betB (betaine-aldehyde dehydrogenase; EC. 1.2.1.8).  
Based on Englesberg’s 
39
 observation that rhamnose positive mutants do not fully 
oxidize rhamnose and excrete small amounts of lactaldehyde into the medium, we 
suggest that betB is the likely cryptic gene.  In response to these findings, we have 
augmented the model and ensured that the end products of the identified meiotrophic 
pathways in strain 91001 are inactive when we simulate the normal state (wild type) 
of our model.  
To further emphasize the utility of CryptFind, we have analyzed the arabinose 
fermentation pathway known to be inactive in strain 91001 
18
.  While it is known that 
meiotrophy is unlikely for this pathway due to a significant frameshift caused by a 
122 basepair deletion in araC 
18
, CryptFind may still be used to identify candidate 
genes responsible for known, or hypothesized, pathway deactivations (see Table 2).  
We note that pseudogene araC is among the short list of candidate genes identified by 
CryptFind. 
 
Nutrient requirements and metabolic efficiency 
In order to determine the wild type YP’s minimum nutritional requirement, we 
allowed for the import of all possible sources of carbon, oxygen, nitrogen, phosphate 
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and sulfur.  Our results indicate that optimal cellular growth requires a carbon, sulfur 
and phosphorus source.  The sulfur requirement can be satisfied either by sulfate, 
thiosulfate or L-cysteine.  The cell also has an obligate requirement for the amino 
acids isoleucine, valine, methionine, and either glycine or threonine.  The only 
obligate amino acid that is not part of the metabolic pathways is methionine, which is 
only imported and directly incorporated into cellular biomass.  Consequently, we 
constrain growth in the YP model by limiting the methionine transport to a maximal 
rate that corresponds to the experimentally reported doubling time of two hours 
40, 41
.  
Based on these observations, we used a medium composed of gluconate, phosphate, 
thiosulfate, methionine, phenylalanine, isoleucine, valine and glycine as a “minimal” 
(MIN) growth medium for the wild type YP simulations.  For simulating the cell’s 
growth in a nutritionally ideal environment, we used the TMH medium 
42
. 
The YP metabolism has previously been characterized as highly inefficient, with only 
58% of the carbon imported into the cell as glucose being assimilated into biomass 
43
.  
A suggested reason for this inefficiency is that YP lacks one of the primary means by 
which bacteria silence their pseudogenes 
44
.  This deficiency could lead to a 
significant amount of metabolic capability being wasted on expression and 
degradation of genes that no longer code for proper functions.  To systematically 
evaluate the metabolic efficiency of iAN818m, we simulated cellular growth for 
multiple different carbon sources.  Since the choice of carbon source and oxygen 
availability may impact the efficiency calculations, we introduced a uniform maximal 
carbon source uptake rate corresponding to 30 carbons, e.g. the maximal uptake rate 
for glucose and glycerol is 5 and 10 mmol/gdw hr, respectively.  The maximal uptake 
rate for oxygen, set to 20 mmol/gdw hr, was never reached.  Based on this result, if 
one assumes that the carbon and oxygen uptake mechanisms of YP have similar 
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capacities to those of other enteropathogens that have much shorter doubling times 
(such as E. coli
11
 and YP’s progenitor Yersinia pseudotuberculosis
40 
(YPS)), one can 
conclude that respiration for YP is not rate limiting.  However, if the uptake of 
oxygen is severely stunted in comparison to other enteropathogens, YP’s cellular 
metabolism would be respiration limited.  Due to a lack of experimental 
measurements as well as YP’s close relationship to YPS and E. coli, our results are 
based on the earlier assumption.  
Figures 2 and 3 demonstrate that the reconstructed metabolic network also is highly 
carbon-inefficient, with a large amount of the imported carbon being wasted in all 
studied conditions.  In Figure 3, we show the model-predicted utilization of the 
central carbon metabolism using either glucose or gluconate as the carbon source in a 
nutrient rich aerobic medium.  In rich media, via deamination, some of the imported 
amino acids can serve as a carbon source.  For example, as shown in Figure 3, 
deamination of glutamate to α-ketoglutarate is a major source of carbon for the citric 
acid cycle.  Additionally, our simulations of YP metabolism for both nutrient rich and 
nutrient poor media show that the activity of the enzyme α-ketoglutarate 
dehydrogenase (EC 1.2.4.2) is either absent or very small when compared to other 
TCA reactions.  This seems to corroborate the prediction that there might be a 
deficiency in the activity of this enzyme in Y. pestis 
45
.   
It is important to note that, as is the case with reported flux solutions for all FBA 
models, calculated flux values that optimize an objective function typically are not 
unique.  The magnitude of the flux degeneracy has been shown to substantially 
depend on environmental conditions and network composition
46
.  In order to evaluate 
the impact of degeneracy on our flux distributions, we conducted a flux variability 
analysis
46
 in a fixed environment for the reactions shown in Figure 3.  Our 
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simulations show that flux degeneracy is not significant for the majority of the 
reactions (see Supplementary Material).    
We find that the YP metabolism is considerably more carbon efficient in the presence 
of oxygen than in anaerobic environments (see Figure 2).  According to the 
stoichiometry of YP’s oxidative phosphorylation, the P/O ratio for NADH in our 
model can vary from 0.66 to 2.  The stoichiometry of proton import in YP via 
oxidative phosphorylation is similar to that of E. coli:  YP, like E. coli, possesses both 
NDH-I and NDH-II types of NADH dehydrogenase enzyme
47
.  Furthermore, the 
cytochrome complement of both organisms consists of cytochrome bd and 
cytochrome o. Protein BLAST analyses verify that there is a high degree of similarity 
(ranging from 65% to 86%) between the subunits of cytochromes of YP and E. coli.  
Based on this resemblance and because of a dearth of studies into the mechanism of 
oxidative phosphorylation in YP, we have used the stoichiometric coefficients from 
the electron transport mechanism of a published model of E. coli
11
.  The calculated 
P/O ratios for our simulations are reported in Table 3.   
While experiments have shown that the growth of YP is robust immediately following 
the incubation in a glucose-rich medium; as the metabolic byproducts accumulate, 
glucose is no longer a suitable carbon source due to rapid acidification of the 
extracellular medium 
34
.  Experimentally, this challenge is overcome by the use of 
gluconate as primary carbon source 
48, 49
.  As can be seen from Table 3 and Figure 2, 
the model identifies gluconate as the carbohydrate in nutritionally minimal 
environments that acidifies the medium the least while maintaining carbon 
efficiencies comparable to that of glucose.  Thus, our model analysis supports the 
time proven choice of gluconate as the ideal carbon source for batch cultivation of 
YP.  Finally, in accordance with experimental observations in nutrient poor and 
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anaerobic conditions 
50
, the model predicts that the presence of CO2 and/or 
bicarbonate potentially improves cellular growth (see Table 3).  
Metabolic robustness 
Genome-scale theoretical models present a powerful tool for the analysis of a cell’s 
strengths and vulnerabilities.  While it is becoming a standard procedure to conduct 
large-scale experimental single-gene knockout screens for organisms such as E. coli 
and S. cerevisiae, this remains a highly non-trivial task for Category A pathogens due 
to restrictions on the use of antibiotics.  We have characterized the resistance of YP to 
possible drug interactions and genetic mutations for all single-gene and double-gene 
knockouts in multiple environments in silico.  We systematically identified all 
essential single reaction (SRKOs) and gene knockouts (SGKOs) as well as synthetic 
lethal mutations (SLMs) (see Figure 4).  We find that in all environments there are 74 
critical SGKOs and 77 SRKOs.  Under aerobic conditions, the model contains 126 
essential SGKOs and 61 SLMs in the TMH medium, while the MIN medium has 168 
critical SGKOs and 56 SLMs.  For both media, absence of oxygen adds 1 SGKO and 
16 SLMs.  Additionally, we identify an additional 1 SGKO and 2 SLMs that are 
solely associated with anaerobic, nutrient poor conditions.   
Nutritionally poor media significantly limit the number of ways the metabolic 
network can incorporate nutrients, and thus, cells growing in these environments are 
more fragile.  The number of growth limiting SGKOs are drastically smaller (>25% 
reduction) for a rich medium in comparison to a poor medium.  A complete list of 
critical genes is given in the Supplementary Material.  
In MIN, over 80% of the extra SGKOs (in comparison to TMH) are involved in the 
production of amino acids that are obligatory for cellular growth.  These amino acids 
are available in TMH, and the removal of their biosynthetic genes has no effect on 
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cellular growth.  Other lethal SGKOs are involved in the production of cell envelope 
material as well as necessary intermediates of the pentose phosphate pathway.  In 
particular, the evolutionary loss of glucose 6-phosphate dehydrogenase (Zwf) in YP 
eliminates the primary path for production of pentose precursors of a number of 
critical pathways 
34
.  Consequently, any perturbation of the alternate (and non-
redundant) pathways for production of these compounds can halt cellular growth. 
Finally, all SLMs from the double-knockout simulation are associated with either a) 
alternate pathways that produce the same critical metabolite (52%), b) a pair of 
critical isozymes (28%) or c) extracellular transport and reaction for in vivo synthesis 
of critical metabolites (20%).  A large majority of these SLMs are associated with five 
critical metabolic pathways:  Oxidative phosphorylation (23%), Arginine 
biosynthesis/urea cycle (18%), Purine biosynthesis (17%), Pentose phosphate 
pathway (16%) and Lysine metabolism (9%).     
Discussion  
To ensure a high level of accord between publicly available experimental 
observations and model predictions, we had to make certain that all non-functional 
metabolic reactions were silenced.  Given the fact that YP is a meiotrophic organism, 
and thus, its genome contains multiple cryptic genes, we needed to develop a method 
to identify these genes and correctly encode their activity in the model.  Our method 
involves comparing single-gene knockouts for a number of select environmental 
conditions, extracting from this collection the few genes that can act as cryptic genes.  
An inspection of our results (see Table 2) shows that the model accurately identifies 
known genes responsible for a phenotypic behavior among the short list of candidate 
genes in all tested cases.  Use of our methodology could serve as a powerful tool in 
 - 13 - 
enhancing the process of genome annotation, development of theoretical models, and 
design of experiments. 
Gene reduction analysis of YP has shown that its genes are being inactivated or 
deleted under selective pressure, and that this process is likely related to the 
interaction of the bacterium with the nutrient rich medium in the host 
51
.  We used the 
genome-scale model to study the metabolic characteristics and cellular robustness of 
YP.  We note that its metabolic needs differ significantly from those of its 
chemoheterotrophic progenitor, Yersinia pseudotuberculosis, as well as other 
members of yersiniae family.  Examinations of the genome of YPS have shown that 
this organism has a full complement of the biosynthetic metabolic pathways 
52
.  
However, an examination of our SGKO and SLM results corroborate the assertion 
that, compared to YPS, YP is more dependent on the host medium to provide its 
nutritional requirements.  Some of the ubiquitous critical knockouts of YP are 
associated with import of obligatory nutrients, such as phenylalanine and methionine 
whose import from the host medium are not need by YPS. 
As is characteristic of parasitic relationships, it has been noted that the metabolism of 
YP is very inefficient 
43
.  Our model simulations (see Figure 2 and Table 3) also point 
to a wasteful metabolism where more than half of the carbons that are imported into 
the cell are excreted as waste material.  The predicted results show that respiratory 
metabolism is more carbon efficient than anoxic metabolism.  Additionally, oxidative 
metabolism produces lower amounts of acidic byproducts, which are known to inhibit 
cellular growth.  Because of YP’s aversion to acidity, the model’s results agree with 
the experimental practice of using gluconate as the carbon source for the batch 
cultivation of YP. 
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Conclusions  
 
Bubonic plague is one of the world’s most dangerous diseases and still afflicts 
thousands of people worldwide.  The discoveries of antibiotic resistant strains of 
Yersinia pestis and an ever-present threat of plague being used as a weapon of 
bioterrorism are added impetuses for studying the physiology of this organism and 
developing new therapeutics.  To aid in this effort, we have developed a highly 
curated genome-scale constraint-based model of metabolism in YP.  Concomitantly, 
we have developed a novel theoretical method for identification of cryptic and 
pseudo-genes which greatly aids the process of model development and gene 
annotation.   
These theoretical tools will allow for faster, more accurate discovery of drug targets 
by identifying the cell’s metabolic weaknesses and strengths.  Such advances are 
always welcome, but in case of extremely deadly pathogens like YP, these tools are 
indispensable since experimental analyses are associated with the need for high-
security laboratory conditions, and in some cases prohibited. 
As an initial use of the model, we have developed new techniques for combining 
mRNA expression data with FBA models (A. Navid, E. Almaas, unpublished work) 
and have applied the new technique to study the YP’s metabolic adaptation following 
its transition from flea gut environment to that of the mammalian host.  Additionally 
we have analyzed YP’s metabolic dynamics after interaction with the antibiotics 
Chloramphenical and Streptomycin.  In the future we plan to use this model to study 
the metabolic capabilities of different biovars of YP as well as their progenitor Y. 
pseudotuberculosis.     
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Methods 
 
Reconstruction of the metabolic network 
Our Yersinia pestis model iAN818m is based on the annotated genome of strain 
91001 
18
 that has been deposited on the KEGG website.  Our model was extensively 
hand-curated to ensure compliance with experimental observations, accounting for the 
activity of 818 of the 1146 metabolism related genes (71%) in the genome.  The 
translated proteins from these genes catalyze 969 metabolic reactions. 
From an extensive literature search and analysis of observed metabolic capabilities, 
we added 37 reactions that are associated with orphan enzymes (see Table 1) in 
addition to 14 non-enzymatic reactions.  When there was a conflict between 
experimental observation and genomic annotation, the experimental observation took 
precedence.  A list of characteristics of the model is given in Table 1, and a complete 
list of the reactions has been included in the Supplementary Material. 
The biomass equation was developed using a variety of data sources:  The amino 
acid
53
 and phospholipid 
54-56
 composition of the biomass are unique to YP.  We 
assumed that the nucleotide composition and the maintenance ATP usage are similar 
to that of YP’s close relative (89% DNA sequence similarity) Escherichia coli 
57
 and 
is set to 7.6.  A variation of this value has negligible impact on the calculated carbon 
efficiency (Supplementary Material).  The composition for the remaining cofactors 
and small molecules are taken from the reported composition of prokaryotes 
58
.   
The primary growth-determining constraint placed on the import of nutrients is an 
upper limit for the import of the obligate amino acid methionine.  The metabolism of 
this nutrient is simple, i.e., it is imported and directly incorporated into the biomass.  
By setting an appropriate upper limit on the import of this nutrient we ensure that the 
growth of YP agrees with observed doubling times.  Additionally, we blocked the 
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import of NH4
+ 
based on observations that most strains of YP fail to show significant 
growth in presence of NH4Cl as the sole source of nitrogen 
33
, the ammonium 
transport facilitator gene (amtB) is strongly down-regulated at 37ºC 
59
, and finally, the 
fact that concentration of this compound is very small in the mammalian host.  Two 
distinct culture media were used for all our simulations.  The “minimal” medium 
contained gluconate, phosphate, glycine/threonine, phenylalanine, methionine, and 
thiosulfate.  For a nutritionally rich environment which would be ideal for cellular 
growth, we used the TMH medium 
42
.   
Flux Balance Analysis (FBA) 
FBA is based on representing all known metabolic reactions of an organisms by the 
stoichiometric matrix, S (m×n), where m is the number of metabolites and n the 
number of different reactions.  Applying the assumptions of mass balance and 
metabolic steady-state, we find the following set of linear equations governing the 
system’s behavior: 
0=S=
dt
dX
j jij
i ∑ ν , 
where Xi is the concentration of metabolite i.  Other limitations that are imposed on a 
system based on experimental studies enforce that the amount of flux through a 
reaction, the amount of nutrients imported, or waste products excreted from the 
organism have a lower and upper boundary: 
βα i ≤≤ν , 
φbχ i ≤≤ , 
where iν and bi are the internal and export/import flux of species i respectively, and α, 
β, χ, and φ are the lower and upper limit for these fluxes.  Finally, FBA utilizes linear 
programming to determine a feasible steady-state flux vector that optimizes an 
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objective function, most commonly chosen to be the production of biomass, i.e. 
cellular growth. 
CryptFind: Identification of potential cryptic/pseudo genes 
The method for identifying cryptic and pseudo genes is based on the ability of FBA to 
predict a gene’s knockout phenotype with high fidelity in quality metabolic 
reconstructions 
60
.  We generate the list of candidate cryptic genes associated with a 
meiotrophic trait by the following two-step process: (1) We initially identify all genes 
that are conditionally essential on a minimal medium only containing the nutrient 
source for which meiotrophy is observed.  (2) We reduce this list by removing genes 
that are conditionally essential for any other nutrient source.  The remaining 
candidates (if any) comprise the final list of cryptic gene candidates.  For example, we 
identify possible cryptic genes responsible for YP’s inability to ferment rhamnose by 
simulating system-wide single-gene knockouts in a MIN medium using rhamnose as 
the primary sugar source instead of gluconate.  We reduce this initial list of cryptic 
gene candidates by removing the genes that are identified as essential through 
knockout analyses for a large array of other possible sugar sources.  For a more 
detailed description of this methodology see the included supplementary material. 
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Figures 
 
 
Figure 1 - Grouping of metabolic reactions according to pathways. 
The Yersinia pestis strain Mediaevalis metabolic network reconstruction consists of 
1020 reactions, separated into the following pathways: 200 Amino Acid, 201 Carbon, 
159 Cofactor, 27 Energy, 134 Membrane, 123 Nucleotide, 142 Transport, and 34 in 
other pathways. 
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Figure 2 - Metabolic efficiency of Yesinia pestis in varied nutritional conditions.   
The calculated efficiency of carbon absorption by Y. pestis for a variety of 
carbohydrates corroborates the experimental observations
43
 that the metabolism of 
this bacterium is wasteful.  Red (blue) symbols indicate aerobic (anaerobic) 
conditions.  Cell growth in nutrient rich or poor media is marked by filled or empty 
symbols, respectively.  H
+
 production is normalized to that in glucose aerobic 
medium.  Carbon efficiency is defined as the ratio of imported carbons from the 
specified source to carbons incorporated in biomass.  
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Figure 3 - Metabolic activity of central carbon metabolism in Y. pestis biovar 
Mediaevalis 
 Calculated reaction fluxes under aerobic TMH conditions with either glucose (GLC) 
or gluconate (GLT) as single carbon source.  The calculated fluxes are given as 
percentage of import flux for GLT (GLC) as upper (lower) value.  In agreement with 
Figure 2, the predicted results point to a wasteful metabolism.    The results also 
support the reported absence or deficiency of α-ketoglutarate dehydrogenase activity 
in Y. pestis
45
.   Metabolite abbreviations are G6P – glucose 6-phosphate; F6P – 
fructose 6-phosphate; GAP – glyceraldehyde 3-phosphate; DHAP – dihydroxyacetone 
phosphate; 6PGLT – 6-phopsho-gluconate; 3PG – 3-phosphoglycerate; PEP – 
phosphoenolpyruvate; PYR – pyruvate; AcCoA – acetyl-CoA; AcP – acetyl 
phosphate; Ac – acetate; Oxal – oxaloacetate; FUM – fumarate; αKG – α-
ketoglutarate; Glu – glutamate; FOR – formate; Orn – ornithine.   
 - 24 - 
 
Figure 4 -Cellular robustness to genetic mutations.   
Statistics of a) single gene knockouts (SGKO) and b) synthetic lethal mutations 
(SLMs) for different environments (all mixtures of aerobic, anaerobic, nutrient poor, 
nutrient rich).  As expected, nutritionally poor media significantly limit the number of 
ways the metabolic network can produce necessary cellular components, and thus, 
cells growing in these environments are more susceptible to the deleterious effects of 
genetic mutations.   
(A) (B) 
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Tables 
Table 1  - Model Statistics 
Coding sequences  
DNA processing   
Cellular processes 
Poorly characterized 
Pseudogenes  
Metabolism 
Genes in the model 
Number of metabolites 
Number of reactions 
   -Annotated genome 
   -Non-enzymatic 
   -Literature 
   -Necessary for growth 
   -Metabolic hole filling 
  4037 
    663 
    825 
  1263 
    141 
  1146 
    818 
    825 
  1020 
        969 
          14 
          20 
          13 
            4 
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Table 2  - List of candidate cryptic/pseudo genes for Y. pestis 
Metabolic loss Possible Cryptic 
Genes 
Reactions 
Biosynthesis of 
gly/thr 
metL 
 
thrB 
thrC 
HOM-L + NADP+ ↔ ASPSA + H+ + NADPH 
ASP-L + ATP ↔ 4PASP + ADP 
ATP + HOM-L → ADP + H
+
 + PHOM 
H2O + PHTHR → 4HTHR + Pi 
H2O + PHOM → Pi+ THR-L 
Biosynthesis of 
val/ile 
ilvC 
 
ilvD 
2AHBUT + H+ + NADPH→ 23DHMP + NADP+ 
ALAC-S + H
+
 + NADPH →23DHMB + NADP
+ 
23DHMP →3MOP + H2O 
23DHMB → 3MOB + H2O 
Biosynthesis of phe pheA
*
 AROG-L+H
+
 ↔PHE-L+H2O+CO2 
Biosynthesis of met metA 
metB
*
 
 
 
 
 
 
metC 
 
 
 
metH 
HOM-L + SUCCOA → COA + SUCHMS 
CYS-L + SUCHMS → CYST-L + H + SUCC 
CYS-L + ACTHMS → CYST-L + 2H
+
 + AC 
SUCHMS+H2O ↔2OBUT+ SUCC+ NH4
+
+ H
+ 
SUCHMS+DMS+3H
+
 ↔ HCYS-L +SUCC+ 2CH4 
ACTHMS+DMS+3H+ ↔ HCYS-L +AC+ 2CH4 
ACTHMS+SECYS →SECYST+AC+H
+
 
CYS-L + H2O → H2S + NH4
+
 + PYR 
CYST-L + H2O → HCYS-L + NH4
+
 + PYR 
CYSTI-L+H2O →PYR+NH4
++TCYS 
SECYST+H2O →SEHCYS+NH4
+
+PYR 
5MTHF + HCYS-L → MET-L + THF 
Fermentation of 
arabinose 
araABC
*
FGH ARAB-LOUT+ATPCYTOSOL+H2O→ 
           ADPCYTOSOL+ARAB-LCYTOSOL+H
+
+Pi 
Fermentation of 
rhamnose 
betB
†
 
 
 
rhaA 
rhaT 
tpiA 
H2O + LADL-L + NAD
+
 → 2H
+
 + LAC-L + NADH 
BETALD + H2O + NAD
+
 → GLYB + 2H+ + NADH 
BETALD + H2O + NADP
+
 → GLYB + 2H
+
 + NADPH 
RMN ↔ RML 
H
+
OUT + RMNOUT → H
+
CYTOSOL + RMNCYTOSOL 
DHAP ↔ G3P 
Fermentation of 
melibiose 
glk 
melB
*
 
ATP + GLC-D → ADP + G6P + H+ 
H
+
OUT + MELIBOUT → H
+
CYTOSOL + MELIBCYTOSOL 
Urease YPO2672 
ureABCD
*
EFG 
UREAOUT ↔ UREACYTOSOL 
UREA+H2O+ 2H
+
 →CO2+ 2NH4
+ 
*
known cryptic/pseudo genes 
†
likely cryptic gene 
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Table 3  -Comparative analysis of optimal growth of Y. pestis utilizing 
different carbon sources.   
Carbohydrate Normalized 
Growth 
Normalized 
CO2 export 
P/O ratio Normalized H
+
 
production 
Aerobic MIN 
galactose 
glucose 
gluconate 
glycerol 
mannitol 
ribose 
 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
 
0.6 
0.4 
1.0 
0.4 
0.4 
0.6 
 
1.3 
1.2 
1.3 
0.8 
1.1 
1.3 
 
1.8  
1.8  
1.0  
2.6  
1.5  
1.8  
Anaerobic MIN 
galactose 
glucose 
gluconate 
mannitol 
ribose 
 
0.1 
0.3 
0.2 
0.2 
0.1 
 
-0.5 
-0.5 
-0.2 
-0.6 
-0.5 
 
N/A 
N/A 
N/A 
N/A 
N/A 
 
1.8  
1.9  
1.1  
1.8  
1.7  
Aerobic TMH 
galactose 
glucose 
gluconate 
glycerol 
mannitol 
ribose 
 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
 
2.1 
0.0 
0.1 
0.4 
0.0 
2.0 
 
1.3 
1.2 
1.2 
1.1 
1.3 
1.3 
 
2.1  
2.0  
2.3  
0.3 
1.8  
0.6  
Anerobic TMH 
galactose 
glucose 
gluconate 
mannitol 
ribose 
 
1.0 
1.0 
1.0 
1.0 
1.0 
 
-0.8 
0.0 
0.0 
0.0 
0.0 
 
N/A 
N/A 
N/A 
N/A 
N/A 
 
4.6 
2.8 
2.9 
3.6 
4.0 
 
